Case File
efta-02031338DOJ Data Set 10OtherEFTA02031338
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-02031338
Pages
5
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
To:
jeevacationtagmail.com[[email protected]]; Jeffrey Epstein[[email protected]]
From:
Paul S Barrett
Sent:
Thur 12/9/2010 4:38:27 PM
Subject: RE: Oil
The switch into the GM Convert is a better place holder...earn a coupon and keep the upside. We still
feel that we will make money on this position.
Paul Barrett, CFA
Managing Director
Global Investment Opportunities Group
JPMorgan Private Bank
From: Jeffrey Epstein [mailto:[email protected]]
Sent: Thursday, December 09, 2010 11:33 AM
To: Paul S Barrett
Subject: Re: Oil a loss on the corn colloar a loss on the gm bonds„ what should we do.
On Thu, Dec 9, 2010 at 11:30 AM, Paul S Barrett smAgm si i9Amo
wrote:
EFTA_R1_00541432
EFTA02031338
Paul Barrett, CFA
Managing Director
Global Investment Opportunities Group
7Pmorgan Private Bank
From: Jeffrey Epstein linailto:jeoacation(atmail.coml
Sent: Thursday, December 09, 2010 11:27 AM
To: Paul S Barrett
Subject: Re: Oil no the range of the calls
On Thu, Dec 9, 2010 at 11:25 AM, Paul S Barrett
90.85 on the 7th of Dec
Range has been 80 — 90.85 over the past 30days
Paul Barrett, CFA
Managing Director
Global Investment Opportunities Group
JPMorgan Private Bank wrote:
EFTA_R1_00541433
EFTA02031339
From: Jeffrey Epstein [mailto:jeevacation(a)gmail.coml
Sent: Thursday, December 09, 2010 11:23 AM
To: Paul S Barrett
Subject: Re: Oil how high did it get in the past two weeks„
On Thu, Dec 9, 2010 at 11:06 AM, Paul S Barrett
> wrote:
We can sell the 90 oil call that expires next week for 30,000. Was cashless upfront.
Ncw risk reversal would be:
Aug2011 contract
100 Call
81.25 Put
Or
105 Call
77.25 Put
Both cashless
I like the li'strategy
EFTA_R1_00541434
EFTA02031340
Paul Barrett, CFA
Managing Director
Global Investment Opportunities Group
7PMorgan Private Bank
This email is confidential and subject to important disclaimers and conditions including on offers
for the purchase or sale of securities, accuracy and completeness of information, viruses,
confidentiality, legal privilege, and legal entity disclaimers, available at
http://nw.jpmorgan.com/pages/disclosures/email.
The information contained in this communication is confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this communication in error, please notify us immediately by
return e-mail or by e-mail to jeevacation@gmail,com, and destroy this communication and all copies thereof,
including all attachments.
This email is confidential and subject to important disclaimers and conditions including on offers
for the purchase or sale of securities, accuracy and completeness of information, viruses,
confidentiality, legal privilege, and legal entity disclaimers, available at
http://vvww.jpmorgan.com/pages/disclosureilemail.
EFTA_R1_00541435
EFTA02031341
The information contained in this communication is confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this communication in error, please notify us immediately by
return e-mail or by c-mail to [email protected], and destroy this communication and all copies thereof,
including all attachments.
This email is confidential and subject to important disclaimers and conditions including on offers
for the purchase or sale of securities, accuracy and completeness of information, viruses,
confidentiality, legal privilege, and legal entity disclaimers, available at
Imp wwjpmoraan Loinipages/disclosurcs email.
The information contained in this communication is confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this communication in error, please notify us immediately by
return e-mail or by e-mail to jeevacationegmail.com and destroy this communication and all copies thereof,
including all attachments.
EFTA_R1_00541436
EFTA02031342
Technical Artifacts (7)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Domain
jeevacationegmail.comDomain
jeevacationtagmail.comEmail
[email protected]Email
[email protected]Email
[email protected]URL
http://nw.jpmorgan.com/pages/disclosures/emailURL
http://vvww.jpmorgan.com/pages/disclosureilemailRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.